ClinicalTrials.Veeva

Menu

Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury (PREDICT-TCM)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Traumatic Brain Injury

Study type

Observational

Funder types

Other

Identifiers

NCT04854954
PREDICT-TCM (29BRC20. 0136)

Details and patient eligibility

About

Patients with moderate traumatic brain injury (mTBI) are 1,5 times more frequent than those with severe TBI and some of them will develop secondary neurologic deterioration (SND) within the first 7 days. However, identifying at risk patients of SND is still challenging. This study aimed to determine risk factors associated with SND after mTBI.

Enrollment

142 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults
  • Admitted in Brest hospital between 2015 and 2018 for moderate TBI, defined by Glasgow coma scale (GCS) score 9-13

Exclusion criteria

  • Non consenting patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems